Conjunctivitis, Bacterial  >>  AzaSite (1% azithromycin ophthalmic solution)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
NCT00105469: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

Completed
3
743
US
AzaSite, Tobramycin
Merck Sharp & Dohme LLC
Bacterial Conjunctivitis
10/05
10/05
NCT00105534: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

Completed
3
685
US
AzaSite, Vehicle
Merck Sharp & Dohme LLC
Bacterial Conjunctivitis
01/06
01/06

Download Options